JMP Securities Upgrades Halozyme Therapeutics (HALO) to Market Outperform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. SPY
3. GLOB
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

October 18, 2011 8:31 AM EDT
Get Alerts HALO Hot Sheet
Price: $98.66 -2%

Rating Summary:
    15 Buy, 5 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
JMP Securities upgraded Halozyme Therapeutics (NASDAQ: HALO) from Market Perform to Market Outperform with a new price target of $9.00.

For more ratings news on Halozyme Therapeutics click here and for the rating history of Halozyme Therapeutics click here.

Shares of Halozyme Therapeutics closed at $6.20 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Upgrades

Related Entities

JMP Securities